![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/EPIGRAL.png)
Share the post "Epigral ‘s Q3 2024-25 Latest News: Profit Up by 111.15% Year-on-Year"
Highlights
🔹 The presented financial data is Consolidated to provide a comprehensive overview of the company performance. 🔹 Sales over the Year and quarter: The company experienced a substantial growth of 36.84 % in the past year, substantial increase in net sales/revenue by 3.06 %. 🔹 Income over the Year and quarter: There has been either a marginal increase or a decline in other income over the past year which is 56.66 %. Marginal decrease of -30.45% in other income during this quarter. 🔹 Profit over the Year and quarter: Significant improvement in profitability for Epigral Limited. Notable increase of 111.13 % in net profit Year to Year, Epigral Limited’s profitability increased by 27.47 % in this quarter. 🔹 EPS over the Year and quarter: EPS increased by 105.33 % Year to Year. EPS increased by 23.91 % in previous quarter. Positive impact on shareholders.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 471.52 Cr | Rs. 626.06 Cr | Rs. 645.24 Cr | + 3.06 % | + 36.84 % |
| Expenses | Rs. 348.98 Cr | Rs. 447.63 Cr | Rs. 462.59 Cr | + 3.34 % | + 32.55 % |
| Operating Profit | Rs. 122.54 Cr | Rs. 178.43 Cr | Rs. 182.65 Cr | + 2.37 % | + 49.05 % |
| OPM % | 25.99 % | 28.5 % | 28.31 % | -0.19 % | + 2.32 % |
| Other Income | Rs. 2.464 Cr | Rs. 5.55 Cr | Rs. 3.86 Cr | -30.45 % | + 56.66 % |
| Interest | Rs. 20.19 Cr | Rs. 27.32 Cr | Rs. 0.07 Cr | -99.74 % | -99.65 % |
| Depreciation | Rs. 30.88 Cr | Rs. 32.25 Cr | Rs. 32.91 Cr | + 2.05 % | + 6.57 % |
| Profit before tax | Rs. 73.93 Cr | Rs. 124.41 Cr | Rs. 153.53 Cr | + 23.41 % | + 107.67 % |
| Tax % | 33.51 % | 35.27 % | 32.56 % | -2.71 % | -0.95 % |
| Net Profit | Rs. 49.08 Cr | Rs. 81.3 Cr | Rs. 103.63 Cr | + 27.47 % | + 111.15 % |
| EPS in Rs | Rs. 11.81 | Rs. 19.57 | Rs. 24.25 | + 23.91 % | + 105.33 % |
Today, we’re looking at Epigral Limited’s financial performance for the Q3(Dec 2024-25).Starting with the top line, the company reported a robust year-over-year sales growth of 36.84 %. However, it did see a marginal increase of 3.06 % from the previous quarter. Expenses ticked up slightly by 3.34 % quarter-on-quarter, aligning with the annual rise of 32.55 %. Operating profit, while up 49.05 % compared to last year, faced a quarter-on-quarter increase of 2.37 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 2.32 %, but a shrinkage of -0.19 % sequentially. Other income fell by -30.45 % compared to the last quarter, despite an annual growth of 56.66 %. Interest expenses dropped significantly by -99.74 % from the previous quarter, yet the year-over-year decrease remains at a moderate -99.65 %. Depreciation costs climbed by 2.05 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 6.57 %. Profit before tax grew annually by 107.67 % but saw an increase from the preceding quarter by 23.41 %.
Tax expenses as a percentage of profits decreased slightly by -0.95 % compared to last year, with a more notable quarter-on-quarter decrease of -2.71 %. Net profit rose by 111.15 % year-on-year but experienced a 27.47 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 105.33 % but a quarterly rise of 23.91 %. In summary, Epigral Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 471.52 Cr | Rs. 626.06 Cr | Rs. 645.24 Cr | + 3.06 % | + 36.84 % |
| Expenses | Rs. 348.98 Cr | Rs. 447.63 Cr | Rs. 462.59 Cr | + 3.34 % | + 32.55 % |
| Operating Profit | Rs. 122.54 Cr | Rs. 178.43 Cr | Rs. 182.65 Cr | + 2.37 % | + 49.05 % |
| Net Profit | Rs. 49.08 Cr | Rs. 81.3 Cr | Rs. 103.63 Cr | + 27.47 % | + 111.15 % |
| EPS in Rs | Rs. 11.81 | Rs. 19.57 | Rs. 24.25 | + 23.91 % | + 105.33 % |
In reviewing Epigral Limited’s 2024-25(Q3) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 36.84 % year-on-year growth, however, there was a minor increase of 3.06 % from the previous quarter. Expenses rose by 32.55 % compared to the previous year, with a 3.34 % increase quarter-on-quarter. Operating Profit surged by 49.05 % annually, and saw a 2.37 % increase from the last quarter.
Net Profit showed yearly increase of 111.15 %, and experienced a 27.47 % increase from the previous quarter. Earnings Per Share (EPS) rose by 105.33 % annually, however rose by 23.91 % compared to the last quarter. In essence, while Epigral Limited exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.
![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/shareholding/group-of-business-people-meeting-and-having-discussion-in-modern-office-video.jpg)
![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/RDBRIL.png)
